Cargando…
Study of Valproic Acid-Enhanced Hepatocyte Steatosis
Valproic acid (VPA) is one of the most widely used antiepilepsy drugs. However, several side effects, including weight gain and fatty liver, have been reported in patients following VPA treatment. In this study, we explored the molecular mechanisms of VPA-induced hepatic steatosis using FL83B cell l...
Autores principales: | Chang, Renin, Chou, Mei-Chia, Hung, Li-Ying, Wang, Mu-En, Hsu, Meng-Chieh, Chiu, Chih-Hsien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789392/ https://www.ncbi.nlm.nih.gov/pubmed/27034954 http://dx.doi.org/10.1155/2016/9576503 |
Ejemplares similares
-
Data on novel DNA methylation changes induced by valproic acid in human hepatocytes
por: Wolters, JarnoEJ, et al.
Publicado: (2017) -
Nuclear and Mitochondrial
DNA Methylation Patterns
Induced by Valproic Acid in Human Hepatocytes
por: Wolters, Jarno E. J., et al.
Publicado: (2017) -
Long-term feeding of high-fat plus high-fructose diet induces isolated impaired glucose tolerance and skeletal muscle insulin resistance in miniature pigs
por: Hsu, Meng-Chieh, et al.
Publicado: (2017) -
Alterations in the hepatocyte epigenetic landscape in steatosis
por: Maji, Ranjan Kumar, et al.
Publicado: (2023) -
Risk Factors of Hyperammonemia in Patients With Epilepsy Under Valproic Acid Therapy
por: Tseng, Yu-Lung, et al.
Publicado: (2014)